期刊文献+

糖尿病患者血浆β血小板球蛋白和血小板第4因子的表达及意义 被引量:1

Expression and Clinical Significance of Plasma β Thromboglobulin and Platelet Factor 4 in Patients with Type 2 Diabetic Mellitus
下载PDF
导出
摘要 目的:探讨血浆β血小板球蛋白(β-TG)和血小板第4因子(PF4)在糖尿病血管并发症形成过程中的作用。方法:ELISA法测定36例2型糖尿病并发血管性疾病患者β-TG和PF4含量,并与48例无血管性病变的2型糖尿病组和42例健康对照组比较。结果:2型糖尿病并发血管性疾病组血浆β-TG和PF4含量显著高于无血管病变组和健康对照组(P<0.01)。其水平高低与糖化血红蛋白(GHb)呈正相关(r=0.687和0.664,P<0.01),与甘油三酯(TG)水平无相关性(r=0.275和0.197,P>0.05)。结论:2型糖尿病患者β-TG和PF4的释放促进了血管病变的发生和发展。 Objective To investigate the role of plasma β thromboglobulin(β-TG)and platelet factor 4(PF4)in the progression of vascular complication in patients with type 2 diabetic mellitus.Methods The contents of β-TG and PF4 in 36 cases of type 2 diabetic mellitus complicated vascular disease were determined by ELISA,and then they were compared with 48 cases of type 2 diabetic mellitus without vascular disease and 42 cases of healthy control.Results The contents of β-TG and PF4 in type 2 diabetic mellitus complicate...
出处 《郧阳医学院学报》 2010年第4期342-343,346,共3页 Journal of Yunyang Medical College
关键词 糖尿病 β血小板球蛋白 血小板第4因子 Type 2 diabetes mellitus βthromboglobulin Platelet factor 4
  • 相关文献

参考文献4

二级参考文献28

  • 1王运来,张启良,曹中栓,陈岚,潘宝华,邓时慧,王春,蒋淑英,王晋源.急性血栓性脑梗塞血浆βTG、PF_4、tPA—的测定[J].中国神经精神疾病杂志,1993,19(1):36-37. 被引量:6
  • 2吴国新,阮长耿.血小板颗粒膜蛋白研究进展[J].中华血液学杂志,1994,15(3):162-164. 被引量:231
  • 3各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33004
  • 4[1]Mcever RP, Beckested JH, Moore KL, et al. GMP140, a platelet α-granule membrane protein is a so synthesized by vascular endothelial ceiling and localized in weibel-palaele bodes. J Clin Invest, 1989, 84: 92-99.
  • 5[2]Tschoepe D, Roesen P, Schwippert B, et al. Platelets in diabetes: the role in the haemostatic regulation in arteriosclerosis. Semin Thromb Hemost,1993, 19: 122-128.
  • 6[4]Craig BT,Katberine A.Size dependent platelet subpopulations relationship of platelet volume to ultra structure enzymatic activity and function.Br J Hematology,1982,50:509-510.
  • 7[6]Milani A,Marra L,Siciliano M,et al.Laboratory parameters in the natural history of liver cirrhosis.Ric Clin Lab,1989,19:173-178.
  • 8Karamanos B, Porta M, Songini M, et al. Different risk factors of microangiopathy in patients with type 1 dabetes mellitus of short versus long duration. The eurodabiddm complication study [J].Diabetologia, 2000, 43(3): 348-55.
  • 9Greaves M, Malia RG, Goodfellow K, et al. Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, control and urinary albumin excretion rate:The EURODIAB IDDM Complications Study [J]. Diabetologia,1997,40(6): 698-705.
  • 10Ingerslev J. Research methodologies in measurement of platelet function, endothelial proteins coagulation factors and flbrinolysis research methodologies in human diabetes. Part 2 [M]. New York:De Gruyter Berlim, 1995. 125-46.

共引文献30

同被引文献10

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部